Overview

EO4010 in Previously Treated Metastatic Colorectal Carcinoma

Status:
Not yet recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
Open-label multicenter study
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Enterome
Treatments:
Nivolumab